Erratum: Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair (Cancer Cell (2019)35(3)(504–518.e7), (S1535610819300546), (10.1016/j.ccell.2019.01.020))

Jianhui Ma; Jorge A. Benitez; Jie Li; Shunichiro Miki; Claudio Ponte de Albuquerque; Thais Galatro; Laura Orellana; Ciro Zanca; Rachel Reed; Antonia Boyer; Tomoyuki Koga; Nissi M. Varki; Tim R. Fenton; Suely Kazue Nagahashi Marie; Erik Lindahl; Timothy C. Gahman; Andrew K. Shiau; Huilin Zhou; John DeGroot; Erik P. Sulman; Webster K. Cavenee; Richard D. Kolodner; Clark C. Chen; Frank B. Furnari

doi:10.1016/j.ccell.2019.04.011

Erratum: Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair (Cancer Cell (2019)35(3)(504–518.e7), (S1535610819300546), (10.1016/j.ccell.2019.01.020))

Jianhui Ma, Jorge A. Benitez, Jie Li, Shunichiro Miki, Claudio Ponte de Albuquerque, Thais Galatro, Laura Orellana, Ciro Zanca, Rachel Reed, Antonia Boyer, Tomoyuki Koga, Nissi M. Varki, Tim R. Fenton, Suely Kazue Nagahashi Marie, Erik Lindahl, Timothy C. Gahman, Andrew K. Shiau, Huilin Zhou, John DeGroot, Erik P. SulmanWebster K. Cavenee, Richard D. Kolodner, Clark C. Chen, Frank B. Furnari

Research output: Contribution to journal › Comment/debate › peer-review

10 Scopus citations

Abstract

Main Text: (Cancer Cell 35, 504–518.e1–e7; March 18, 2019)In the originally published version of this article, a few errors were made in and related to Table S2. We analyzed 44 samples instead of 43 samples. The RPKM value for FGFR2 and FGFR3 was mistakenly copied as the RPMK value of FGFR1. The expression level of PTEN and FGFR2 was determined by mean value instead of median value, which for PTEN is 2.6 and for FGFR2 is 2.1. In the legend for Figure 1D, the orange rectangle indicates all radiation-sensitive samples in the PTEN high group showed low level of FGFR2 expression. The information in Table S2, the Figure 1D legend, and the “Analysis of patient derived GSC lines” section of the STAR Methods have now been corrected in the online article. We apologize for any confusion these errors may have caused.

Original language	English (US)
Pages (from-to)	816
Number of pages	1
Journal	Cancer cell
Volume	35
Issue number	5
DOIs	https://doi.org/10.1016/j.ccell.2019.04.011
State	Published - May 13 2019

ASJC Scopus subject areas

Oncology
Cell Biology
Cancer Research

Access to Document

10.1016/j.ccell.2019.04.011

Fingerprint

Dive into the research topics of 'Erratum: Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair (Cancer Cell (2019)35(3)(504–518.e7), (S1535610819300546), (10.1016/j.ccell.2019.01.020))'. Together they form a unique fingerprint.

Cite this

Ma, J., Benitez, J. A., Li, J., Miki, S., Ponte de Albuquerque, C., Galatro, T., Orellana, L., Zanca, C., Reed, R., Boyer, A., Koga, T., Varki, N. M., Fenton, T. R., Nagahashi Marie, S. K., Lindahl, E., Gahman, T. C., Shiau, A. K., Zhou, H., DeGroot, J., ... Furnari, F. B. (2019). Erratum: Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair (Cancer Cell (2019)35(3)(504–518.e7), (S1535610819300546), (10.1016/j.ccell.2019.01.020)). Cancer cell, 35(5), 816. https://doi.org/10.1016/j.ccell.2019.04.011

Erratum: Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair (Cancer Cell (2019)35(3)(504–518.e7), (S1535610819300546), (10.1016/j.ccell.2019.01.020)). / Ma, Jianhui; Benitez, Jorge A.; Li, Jie et al.
In: Cancer cell, Vol. 35, No. 5, 13.05.2019, p. 816.

Research output: Contribution to journal › Comment/debate › peer-review

Ma, J, Benitez, JA, Li, J, Miki, S, Ponte de Albuquerque, C, Galatro, T, Orellana, L, Zanca, C, Reed, R, Boyer, A, Koga, T, Varki, NM, Fenton, TR, Nagahashi Marie, SK, Lindahl, E, Gahman, TC, Shiau, AK, Zhou, H, DeGroot, J, Sulman, EP, Cavenee, WK, Kolodner, RD, Chen, CC & Furnari, FB 2019, 'Erratum: Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair (Cancer Cell (2019)35(3)(504–518.e7), (S1535610819300546), (10.1016/j.ccell.2019.01.020))', Cancer cell, vol. 35, no. 5, pp. 816. https://doi.org/10.1016/j.ccell.2019.04.011

@article{aa36bed4f92b4dacb0ee17f8b3c71b54,

title = "Erratum: Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair (Cancer Cell (2019)35(3)(504–518.e7), (S1535610819300546), (10.1016/j.ccell.2019.01.020))",

abstract = "Main Text: (Cancer Cell 35, 504–518.e1–e7; March 18, 2019)In the originally published version of this article, a few errors were made in and related to Table S2. We analyzed 44 samples instead of 43 samples. The RPKM value for FGFR2 and FGFR3 was mistakenly copied as the RPMK value of FGFR1. The expression level of PTEN and FGFR2 was determined by mean value instead of median value, which for PTEN is 2.6 and for FGFR2 is 2.1. In the legend for Figure 1D, the orange rectangle indicates all radiation-sensitive samples in the PTEN high group showed low level of FGFR2 expression. The information in Table S2, the Figure 1D legend, and the “Analysis of patient derived GSC lines” section of the STAR Methods have now been corrected in the online article. We apologize for any confusion these errors may have caused.",

author = "Jianhui Ma and Benitez, {Jorge A.} and Jie Li and Shunichiro Miki and {Ponte de Albuquerque}, Claudio and Thais Galatro and Laura Orellana and Ciro Zanca and Rachel Reed and Antonia Boyer and Tomoyuki Koga and Varki, {Nissi M.} and Fenton, {Tim R.} and {Nagahashi Marie}, {Suely Kazue} and Erik Lindahl and Gahman, {Timothy C.} and Shiau, {Andrew K.} and Huilin Zhou and John DeGroot and Sulman, {Erik P.} and Cavenee, {Webster K.} and Kolodner, {Richard D.} and Chen, {Clark C.} and Furnari, {Frank B.}",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Inc.",

year = "2019",

month = may,

day = "13",

doi = "10.1016/j.ccell.2019.04.011",

language = "English (US)",

volume = "35",

pages = "816",

journal = "Cancer cell",

issn = "1535-6108",

publisher = "Cell Press",

number = "5",

}

TY - JOUR

T1 - Erratum

T2 - Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair (Cancer Cell (2019)35(3)(504–518.e7), (S1535610819300546), (10.1016/j.ccell.2019.01.020))

AU - Ma, Jianhui

AU - Benitez, Jorge A.

AU - Li, Jie

AU - Miki, Shunichiro

AU - Ponte de Albuquerque, Claudio

AU - Galatro, Thais

AU - Orellana, Laura

AU - Zanca, Ciro

AU - Reed, Rachel

AU - Boyer, Antonia

AU - Koga, Tomoyuki

AU - Varki, Nissi M.

AU - Fenton, Tim R.

AU - Nagahashi Marie, Suely Kazue

AU - Lindahl, Erik

AU - Gahman, Timothy C.

AU - Shiau, Andrew K.

AU - Zhou, Huilin

AU - DeGroot, John

AU - Sulman, Erik P.

AU - Cavenee, Webster K.

AU - Kolodner, Richard D.

AU - Chen, Clark C.

AU - Furnari, Frank B.

PY - 2019/5/13

Y1 - 2019/5/13

N2 - Main Text: (Cancer Cell 35, 504–518.e1–e7; March 18, 2019)In the originally published version of this article, a few errors were made in and related to Table S2. We analyzed 44 samples instead of 43 samples. The RPKM value for FGFR2 and FGFR3 was mistakenly copied as the RPMK value of FGFR1. The expression level of PTEN and FGFR2 was determined by mean value instead of median value, which for PTEN is 2.6 and for FGFR2 is 2.1. In the legend for Figure 1D, the orange rectangle indicates all radiation-sensitive samples in the PTEN high group showed low level of FGFR2 expression. The information in Table S2, the Figure 1D legend, and the “Analysis of patient derived GSC lines” section of the STAR Methods have now been corrected in the online article. We apologize for any confusion these errors may have caused.

AB - Main Text: (Cancer Cell 35, 504–518.e1–e7; March 18, 2019)In the originally published version of this article, a few errors were made in and related to Table S2. We analyzed 44 samples instead of 43 samples. The RPKM value for FGFR2 and FGFR3 was mistakenly copied as the RPMK value of FGFR1. The expression level of PTEN and FGFR2 was determined by mean value instead of median value, which for PTEN is 2.6 and for FGFR2 is 2.1. In the legend for Figure 1D, the orange rectangle indicates all radiation-sensitive samples in the PTEN high group showed low level of FGFR2 expression. The information in Table S2, the Figure 1D legend, and the “Analysis of patient derived GSC lines” section of the STAR Methods have now been corrected in the online article. We apologize for any confusion these errors may have caused.

UR - http://www.scopus.com/inward/record.url?scp=85065184491&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065184491&partnerID=8YFLogxK

U2 - 10.1016/j.ccell.2019.04.011

DO - 10.1016/j.ccell.2019.04.011

M3 - Comment/debate

C2 - 31085179

AN - SCOPUS:85065184491

SN - 1535-6108

VL - 35

SP - 816

JO - Cancer cell

JF - Cancer cell

IS - 5

ER -

Erratum: Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair (Cancer Cell (2019)35(3)(504–518.e7), (S1535610819300546), (10.1016/j.ccell.2019.01.020))

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this